Sysgroup Share Discussion Threads

[empirestate] 10/8/2010 11:57

calculating from the 5th, by my reckoning blackrock have 1,912,050 to go considering trades on 6th, 9th and 10th

[empirestate] 09/8/2010 21:12

since the 3rd august (the day after the blackrock transaction date) there has been 5,297,000 shares bought. with 116 million shares in issue we should be seeing an RNS any day now. with this amount of continuous more or less daily buying it shouldn't take long to take out blackrock totally and then earnings forecasts for 2010/11 can be priced in. well worth the wait which at this rate could be a week or so, fascinating

[waterloo01] 09/8/2010 17:29

Not new, news but I wonder if Emis or ANO might be looking to buy SYS?

EMIS and System C link up at Aintree

For more news:

[empirestate] 09/8/2010 10:33

we are looking good to go now a premium is being paid. significant buying over the last couple of weeks

[empirestate] 08/8/2010 19:51

looks like a set price deal for the buyer out of blackrocks stake

[empirestate] 08/8/2010 19:49

quite suprising how the market is not letting the price improve with the amount of buying that is evident.

[waterloo01] 06/8/2010 16:47

More serious buys of late including over 1.6m shares today! Someone is stake building.

[waterloo01] 09/7/2010 16:09

Some big buys today (directors?) over 4m sharesin 3 transactions

[stegrego] 16/6/2010 21:45

Healthcare systems open to a new generation
By Philip Stafford

Published: June 16 2010

After a lost decade, the UK healthcare software market is opening up to a new generation of companies.

Government spending and media attention for much of the past 10 years has centred on the flagship £12.7bn National Programme for IT, an all-encompassing plan to modernise and connect large parts of the IT system of the NHS in England and Wales.

But the scale and complexity of the project led to long delays and contractors had their fingers burnt. Isoft, once worth £1bn, almost collapsed while BT's Global Services division attributed a significant part of its £1.3bn writedown in 2008-09 to contract delays within the project.

This year has seen officials responsible for its implementation admitting that the National Programme will not deliver all that it intended , most notably in the critical area of patient care records.

Its breakdown, and government plans for the NHS to make at least £20bn in efficiency cuts, has given emerging companies such as Emis, System C Healthcare,Iris Software and INPS rapid inroads into the market.

[gerdmuller] 21/5/2010 15:26

Looking at ADVFN this is down over 17 percent in a week. The question is will it go back up when if the market rises.

[stegrego] 21/5/2010 15:15

If you stuck your head out of the window, you would see that the whole of the market is selling off over the past few weeks.

This has fallen no more than everything else.

[gerdmuller] 21/5/2010 15:14

I think everyone has given up with these. Can't blame them they just seem to be going nowhere apart from down.

I think small cos like this are fast wondering why they bother being quoted with all the cost and trouble involved.

[dsmith4] 12/5/2010 21:41

Lib Dems and Cons agreed that NHS spend is ringfenced - will rise in real terms over next 5 years each year - must be good for SYS?

[gerdmuller] 12/5/2010 10:40

The good thing about cos like this is that they can fall a lot on low volume but they can also rise quite quickly on low volume as well.

[gerdmuller] 12/5/2010 09:24

At last some news. Let's hope this can get some interest back into these.

[engineer66] 14/4/2010 16:11

Some huge sales from 9 to 12 April someone is still piling out at 37p.
Not sure that it's immune from NHS cuts.

[gerdmuller] 12/4/2010 16:57

This one does actually sometimes go up.

Wonders will never cease.

It should come with a warning sign that the share price of this company can go up as well as down.

[stegrego] 25/3/2010 08:16

Just poked a toe in at 40.2 when price was 39-42

Clearly still a seller around or overhang, but this looks a decent bet from this level.

[melody9999] 25/3/2010 00:19

its hit my radar - the fundamentals and company outlook are positive but sentiment not so at present it seems

[engineer66] 23/3/2010 14:55

Fairly persistent selling so my guess is that its back to 38p and that is probably the right level given "current period of change in the market place".

[gerdmuller] 23/3/2010 10:53

waterloo01,

I tend to agree with you. This company to me seems fundamentally sound and from what has been said it doesn't seem that it will be affected too much by the cuts in NHS spending.

One of the most boring companies I have followed price wise but being boring is not always a bad thing.

I feel that much of the downward price movement is related to lack of patience with this one rather than any fundamental problem.

[waterloo01] 17/3/2010 20:17

From the last results: Can't see many issue here! £16m in cash, revenues and profits up and good forecaste.

System C Healthcare plc ("the Group"), a leading independent provider of
information solutions and services to the UK health and social care sectors,
announces its unaudited half-yearly results for the six months ended 30 November 2009.

Financial Highlights
The financial highlights for the six months ended 30 November 2009 are:

* Revenue up 77% at GBP18.3m (2008: GBP10.4m), including 34% organic growth (2008: 21%)
* Profit before taxation increased by 49% to GBP2.8m (2008: GBP1.9m)
* EPS up 33% to 2.24p per share (2008: 1.69p per share)
* Increased cash position, with cash of GBP16.0m (2008: GBP13.7m)
* Interim dividend 0.25 pence per share (2008: 0.22 pence per share)
* Proportion of product sales increased to 48% of group turnover (2008: 24%)
* 11 deployments of Medway Sigma products
* Acquisition of Liquidlogic to create the UK's first major combined health and social care IT company
* Healthy pipeline of product and services opportunities for this financial year and beyond

Commenting on these results, Chief Executive Dr Ian Denley said:

"We are continuing to benefit from our reputation for quality and delivery.
System C is known for delivering products and solutions that work, and for
delivering them on time and on budget. This, together with the strong synergy
between the products and services divisions, is driving our continued
year-on-year growth.


"We have worked hard to develop the Group on all fronts to ensure that we
benefit from the current period of change in our market place. Indeed, our sales pipeline for both products and services looks very healthy and we are confident of reporting continuing growth through the second half of the year and beyond."

[waterloo01] 17/3/2010 20:10

What constrained NHS spending! The part failure of NPfIT is good news for SYS as spending by authorities has been held off because of it (ie can't do much that CFH didn't approve of), but it's now freed up and trusts/hospitals et al are now much free'er to purchase, and SYS systems/services are in demand. Many will be placing orders before April 5th.

I suspect the next update will be V good with a positive outlook (with the given that an election almost always causes a pause in all govt work/spending, but that's always tempory).

Having said that, someone might know something untoward about SYS. But I can't help but see the share price action as decline mainly due to lack of any news and profile.

[engineer66] 12/3/2010 15:07

I'd like to see SYS do well but there's not much support above 40p. Two concerns are very strong competition from larger companies and the prospect of constrained NHS spending.

[waterloo01] 10/3/2010 17:59

Not sure whats behind the lack of faith here, but according to a Kable report on the NHS IT market, they look well set for some interesting growth and recurring revenues. Maybe the company need to do a bit more in the way of building investor confidence!

Report done in Mid 2009

"The UK public healthcare ICT market totalled £2,342m in 2007-08 and £2,603m in 2008-09. It is forecast to grow to £3,488m by 2013-14, which represents a compound annual growth rate (CAGR) of 6.9%. Recessionary pressures have prevented the industry from growing.

This growth is driven primarily by software revenues, with a CAGR of 36.3%, primarily the CRS software package, which includes clinical, logistical and managerial applications, ranging from patient administration systems to more complex operations such as asset/contract management and risk assessment".